Human medicines European public assessment report (EPAR): Ambrisentan Mylan, ambrisentan, Date of authorisation: 20/06/2019, Revision: 5, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 April 2024 - 9:44

Human medicines European public assessment report (EPAR): Ambrisentan Mylan, ambrisentan, Date of authorisation: 20/06/2019, Revision: 5, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ambrisentan-mylan

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters